Patients taking drugs manufactured by Pfizer, Eli Lilly & Co., and AbbVie for arthritis may find new warnings attached to those medications. The FDA is seeking additional language warning of serious side effects and possible fatalities associated with the drugs.
The medications are part of a class of arthritis drugs known as JAK inhibitors. They work by blocking enzymes in the body known to cause arthritic inflammation ...
continue reading...